The Centre for Trade and Development (Centad), New Delhi, is an independent, not-for-profit organisation that carries out policy research and advocacy on trade and development issues, with a focus on South Asia.
This e-newsletter alerts subscribers to news, announcements, publications and analyses uploaded on Centad’s website, www.centad.org.
FII, who had turned away from the Indian equity market last year, seem to be returning back. Since the beginning of the current financial year, they have already invested more than Rs 1,000 crore into the domestic stocks.
US to ‘facilitate’ Indian technology proposal in climate deal
The US has shown its deep interest in the Indian proposal to create a global network of climate technology centres and is of the say that it deserves to make it to a UN climate change agreement scheduled for later this year.
At the time when most of the global auto players are striving hard to regain their position, car makers in India have succeeded in expanding their presence overseas.
Indian drug makers welcome to join ‘patent pool’ prog: GSK
Global drug major GlaxoSmithKline has given the open proposal to the Indian drug makers to join its patent pool’ programme aimed at developing low cost drugs for 16 neglected tropical diseases in poor countries.
India along with Japan and China is among the top five countries in the Asia-Pacific region to sign up merger and acquisition deals (M&A) in the first quarter of this fiscal.
Pharma exporters to buck trend, to grow 16% in 09-10
According to the recent survey done by the Federation of Indian Chambers of Commerce and Industry (Ficci), at the time when most of the industrial sectors are expecting negligible growth in exports during 2009-10, pharmaceutical exporters have forecast a rise of 16 per cent.